Blood and marrow transplant and cellular therapy program

Blood and Marrow Transplant and Cellular Therapy Program

Since 1980, Children’s Wisconsin has been home to a renowned Blood and Marrow Transplant (BMT) and Cellular Therapy Program. Having performed over 1,500 transplants, our experienced team provides comprehensive, high-quality care to children and young adults, regardless of the donor, transplant type, or therapy used. We are dedicated to managing every step of the transplant process with precision and compassion.

About the Program

Our BMT and Cellular Therapy Program is a collaborative effort between:

• MACC Fund Center for Cancer and Blood Disorders at Children’s Wisconsin
• The Medical College of Wisconsin
• Versiti Blood Research Institute
• Froedtert Hospital

These institutions share resources and expertise to offer comprehensive treatment options, with a focus on innovative therapies and clinical research. Together, we hold FACT accreditation, a prestigious designation that reflects our commitment to excellence.

Comprehensive Care and Expertise

Our team, made up of board-certified physicians, advanced practice providers, transplant coordinators, nurses, and support staff, is internationally recognized for its expertise in pediatric transplants. We specialize in both autologous (self-donated) and allogeneic (donor-based) transplants and offer cutting-edge therapies, such as:

• CART Cell Therapy
• Gene Therapy for hematologic disorders
• Peripheral Blood Stem Cell Collections
• Auto and allogeneic Transplants

Our program boasts one of the top 10 one-year survival rates for pediatric bone marrow transplants in the United States, reflecting our dedication to successful patient outcomes.

Partnerships and Research

Our close proximity to the Center for International Blood and Marrow Transplant Research provides unique opportunities for our physicians to engage in groundbreaking outcomes research.

Other areas of laboratory research include:

• Graft-versus-host disease (GVHD) — A serious condition where donor cells attack the recipient's body.
• Graft-versus-leukemia effect — A phenomenon that reduces the chance of leukemia relapse.
• Immune system rebuilding — Exploring new ways to restore the immune system after transplant.

These studies are instrumental in advancing treatment methods and improving patient care.

Our Approach to Care

From the first phone call to post-transplant recovery, we provide personalized, compassionate care. Our team works closely with each family to ensure they fully understand their child's condition and treatment options. Through our Next Steps Survivorship Program, we support patients in transitioning to healthy, productive lives post-treatment.

Patient Referrals and Appointments

At Children’s Wisconsin, we are committed to a swift and seamless intake process for all new patients. Our team works closely with referring physicians and insurance companies to ensure timely treatment.

For more information or to make an appointment, please contact our BMT Coordinators at (414) 266-2420 or email us.

Contact Information

• Bone Marrow Transplant and Cellular Therapy: Call (414) 266-2420 for more information.
• Referring a Patient for Gene Therapy: Contact our BMT Coordinators at (414) 266-7491.
• Cytotoxic T Cells: For more information on T-cell therapy, call (414) 266-2420.

Safety, Quality and Outcomes

Children’s Wisconsin is proud to have one of the top 10 one-year survival rates for pediatric bone marrow transplants in the country. We prioritize patient safety and quality care, with transparent outcomes data to help families and providers make informed decisions.

For additional information on our survival rates to see how we rank nationally, visit the National Marrow Donor Program Website. Children's Wisconsin | NMDP